Increasing lipid screenings in children 9–11 years old at a federally qualified health center - A quality improvement project



      Coronary artery disease (CAD) remains the leading cause of death in the U.S. Atherosclerotic changes leading to CAD begin in early childhood. Universal lipid screenings remain low nationwide despite the 2011 National Heart, Lung, and Blood Institute's (NHLBI) Expert Panel Guidelines.

      Local problem

      The aim of this quality improvement project was to examine the benefit of an educational intervention on the implementation of universal lipid screening guidelines within a federally qualified health center tasked with providing care to a high-risk population.


      An educational intervention was offered detailing the 2011 NHLBI guidelines. A total of seven medical providers participated in the intervention.


      Following the intervention, a pre- and post- knowledge survey was given to assess improvement in knowledge. A retrospective chart review was performed to evaluate application to practice.


      The number of lipid screenings improved from 7.8% (n = 384) pre-intervention to 39.2% (n = 74) post intervention. There was a statistically significant increase in screenings post-intervention t (456) = 7.842, p = .000, two-tailed).


      More studies are needed to adequately identify the impact of universal screening guidelines on the health of both children and adults alike.

      Practice implications

      Universal lipid screenings remain promising in early identification of CAD in the pediatric population. Interventions related to expanding the knowledge of healthcare providers, patients, and families are key to decreasing CAD morbidity and mortality.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • American Heart Association
        Heart disease and stroke statistics 2017 at-a-glance.
        (Retrieved from)
        • Belamarich P.F.
        Counterpoint: The evidence does not support universal screening and treatment in children.
        Journal of Clinical Lipidology. 2015; 9 (Retrieved from): S101
        • Benjamin E.J.
        • Virani S.S.
        • Callaway C.W.
        • Chamberlain A.M.
        • Chang A.R.
        • Cheng S.
        • American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
        Heart disease and stroke statistics-2018 update: A report from the American Heart Association.
        Circulation. 2018; 137: e67-e492
        • Berger J.H.
        • Chen F.
        • Faeber J.
        • O’Byrne M.
        • Brothers J.
        Adherence with lipid screening guidelines in standard- and high-risk children and adolescents.
        American Heart Journal. 2021; 232: 39-46
        • Bohnet-Joschko S.
        • Boutsioli Z.
        Intercultural dialogue on health economics, management, and policy: Challenges and chances.
        Athens institute for education and research, Athens2014: 117-128 (Retrieved from)
        • Brzeziński M.
        • Metelska P.
        • Myśliwiec M.
        • Szlagatys-Sidorkiewicz A.
        Lipid disorders in children living with overweight and obesity- large cohort study from Poland.
        Lipids in Health and Disease. 2020; 19: 1-9
        • DeSantes K.
        • Dodge A.
        • Eickhoff J.
        • Petersen A.L.
        Improving universal pediatric lipid screening.
        The Journal of Pediatrics. 2017; 188: 87-90
        • de Ferranti S.D.
        • Rodday A.M.
        • Parsons S.K.
        • Cull W.L.
        • O’Connor K.G.
        • Daniels S.R.
        • Leslie L.K.
        Original articles: Cholesterol screening and treatment practices and preferences: A survey of United States pediatricians.
        The Journal of Pediatrics. 2017; 18599-105e2
        • de Ferranti S.D.
        • Steinberger J.
        • Ameduri R.
        • Baker A.
        • Gooding H.
        • Kelly A.S.
        • Zaidi A.N.
        Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association.
        Circulation. 2019; 139: e603-e634
        • Gilbertson S.
        • Graves B.A.
        Motivating parents to promote cardiovascular health in children.
        Journal of Cardiovascular Nursing. 2015; 1: E8-18
        • Gourgari E.
        • Dabelea D.
        • Rother K.
        Modifiable risk factors for cardiovascular disease in children with type 1 diabetes: Can early intervention prevent future cardiovascular events?.
        Current Diabetes Reports. 2017; 17: 134
        • Grundy S.M.
        • Stone N.J.
        • Bailey A.L.
        • Beam C.
        • Birtcher K.K.
        • Blumenthal R.S.
        • Saseen J.J.
        2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.
        Journal of the American College of Cardiology (JACC). 2019; 73: e285-e350
        • Kelishadi R.
        • Haghdoost A.A.
        • Moosazadeh M.
        • Keikha M.
        • Aliramezany M.
        A systematic review and meta-analysis on screening lipid disorders in the pediatric age group.
        Journal of Research in Medical Sciences. 2015; 20: 1191-1199
        • Kern L.
        • Crow J.
        • Williams C.B.
        • Boies E.
        • Gahagan S.
        • Rhee K.E.
        Increasing universal lipid screening among 9- to 11-year-old children through a quality improvement initiative.
        Clinical Pediatrics. 2017; 7: 640
        • Kulshreshtha A.
        • Goyal A.
        • Dabhadkar K.
        • Veledar E.
        • Vaccarino V.
        Urban-rural differences in coronary heart disease mortality in the United States: 1999–2009.
        Public Health Reports. 2014; 129: 19-29
        • Lartey A.
        • Marquis G.
        • Aryeetey R.
        • Nti H.
        Lipid profile and dyslipidemia among school-age children in urban Ghana.
        BMC Public Health. 2018; 18: 320
        • Livernois C.
        Demographics of patients shift as Federally Qualified Health Centers expand.
        (Retrieved from)
        • Lozano P.
        • Henrikson N.B.
        • Morrison C.C.
        • Dunn J.
        • Nguyen M.
        • Blasi P.R.
        • Whitlock E.P.
        Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: Evidence report and systematic review for the US preventive services task force.
        JAMA: Journal of the American Medical Association. 2016; 316: 634
        • Magnussen C.G.
        • Venn A.
        • Thomson R.
        • Juonala M.
        • Srinivasan S.R.
        • Viikari J.S.
        • Raitakari O.T.
        Clinical research: The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood. Evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (childhood determinants of adult health) study.
        Journal of the American College of Cardiology. 2009; : 53860-53869
        • Mihalopoulos N.L.
        • Stipelman C.
        • Hemond J.
        • Brown L.L.
        • Young P.C.
        Original article: Universal lipid screening in 9- to 11-year-olds before and after 2011 guidelines.
        Academic Pediatrics. 2018; 18: 196-199
        • National Heart, Lung, and Blood Institute
        Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report.
        Pediatrics. 2011; 128: S213-S256
        • National Heart, Lung, and Blood Institute
        Coronary heart disease.
        (Retrieved from)
        • Pettigrew A.
        • Whipp R.
        Managing change for competitive success.
        Blackwell Publishing, Oxford1991
        • Rogers R.
        • Eagle T.
        • Sheetz A.
        • Woodward A.
        • Leibowitz R.
        • Song M.
        • Sylvester R.
        • Corriveau N.
        • Kline-Rogers E.
        • Jiang Q.
        • Jackson E.
        • Eagle K.
        The relationship between childhood obesity, low socioeconomic status, and race/ethnicity: Lessons from Massachusetts.
        Childhood Obesity. 2015; 11
        • Smith A.J.
        • Turner E.L.
        • Kinra S.
        Universal cholesterol screening in childhood: A systematic review.
        Academic Pediatrics. 2016; 16: 716-725
        • Sriram S.
        • St. Sauver J.L.
        • Jacobson D.J.
        • Fan C.
        • Lynch B.A.
        • Cristiani V.
        • Kumar S.
        Temporal trends in lipid testing among children and adolescents: A population based study.
        Preventive Medicine Reports. 2017; 8: 267-272
        • Sultan S.
        • Dowling M.
        • Kirton A.
        • DeVeber G.
        • Linds A.
        • Elkind M.
        Dyslipidemia in children with arterial ischemic stroke: Prevalence and risk factors.
        Pediatric Neurology. 2017; 78: 46-54
        • U.S. Preventive Services Task Force
        Final recommendation statement: Lipid disorders in children and adolescents: Screening.
        (Retrieved from)
        • Wilson D.P.
        • Davis S.
        • Matches S.
        • Shah D.
        • Leung-Pineda V.
        • Mou M.
        • Bowman W.P.
        Universal cholesterol screening of children in community-based ambulatory pediatric clinics.
        Journal of Clinical Lipidology. 2015; 9: S88-S92
        • World Health Organization
        Advocacy, communication, and social mobilization for TB control: A guide to developing knowledge, attitude and practice surveys.
        (Retrieved from)